Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
FDMT
Stock Latest News
Company Announcements
4D Molecular Therapeutics Posts Strong 4D-150 Trial Results
22h ago
8K
FDMT
Premium
Ratings
4D-150’s Durable Efficacy and Clean Safety Profile Support Buy Rating and Unchanged $36 Price Target
1d ago
FDMT
Premium
Ratings
4D Molecular Therapeutics Buy Rating Reaffirmed on 4D-150 Pivotal Trial Momentum; Price Target Maintained at $36
21d ago
FDMT
Premium
Company Announcements
4D Molecular Therapeutics Secures $200 Million Loan Facility
22d ago
8K
FDMT
Premium
The Fly
4D Molecular completes enrollment in 4FRONT-2 trial
22d ago
FDMT
Premium
Company Announcements
4D Molecular Therapeutics Stockholders Back Directors and Governance
29d ago
8K
FDMT
Premium
Ratings
Analyst Reiterates Buy on 4D Molecular Therapeutics as Wet AMD Gene Therapy Advances, Keeps $36 Price Target Unchanged
2M ago
FDMT
Premium
Ratings
Daniel Giraldo Reiterates Buy on 4D Molecular Therapeutics, Citing Strong 4D-150 Progress and Undervalued Upside vs. $29 Price Target
2M ago
FDMT
Premium
The Fly
4D Molecular price target lowered to $33 from $38 at Goldman Sachs
2M ago
FDMT
Premium
The Fly
4D Molecular files $400M mixed securities shelf
2M ago
FDMT
Premium
The Fly
4D Molecular reports Q1 EPS ($1.01), consensus ($1.00)
2M ago
FDMT
Premium
The Fly
4D Molecular price target lowered to $23 from $45 at Evercore ISI
3M ago
FDMT
Premium
Company Announcements
4D Molecular Therapeutics Consolidates Financial Leadership Under New Role
4M ago
8K
FDMT
Premium
The Fly
4D Molecular assumed with a Buy at Jefferies
4M ago
FDMT
Premium
Company Announcements
Reimbursement and Pricing Pressures Threaten Commercial Outlook for 4D Molecular Therapeutics’ Gene Therapies
4M ago
FDMT
Premium
Pre-Earnings
4D Molecular Therapeutics, Inc. (FDMT) Q4 Earnings Cheat Sheet
5M ago
FDMT
Premium
The Fly
4D Molecular completes enrollment for 4FRONT-1 Phase 3 trial
5M ago
FDMT
Premium
The Fly
4D Molecular assumed with an Overweight at Barclays
6M ago
FDMT
Premium
Company Announcements
4D Molecular Therapeutics Restructures Equity via Warrant Exchange
6M ago
8K
FDMT
Premium
The Fly
4D Molecular announces employment inducement grants
6M ago
FDMT
Premium
Company Announcements
4D Molecular Therapeutics Expands Leadership With New Director Appointment
6M ago
8K
FDMT
Premium
Ratings
4D Molecular Therapeutics: Encouraging Early CF Gene Therapy Signals Tempered by Limited Data, Supporting a Neutral Hold Rating
7M ago
FDMT
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
